Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of

The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) October 6, 2011

 

 

NEOGEN CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

MICHIGAN   0-17988   38-2367843

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

620 Lesher Place Lansing, Michigan   48912
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code 517-372-9200

Not Applicable

(Former name or former address, if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.07 Submission of Matters to a Vote of Security Holders

On October 6, 2011, Neogen Corporation (the “Company”) held its 2011 Annual Meeting of Shareholders, at which meeting 21,566,366 of the 23,315,559 shares outstanding and entitled to vote were present and voted. The matters listed below were submitted to a vote of the shareholders though the solicitation of proxies. The proposals are described in detail in the Company’s Proxy Statement dated as of, and filed with Securities and Exchange Commission on September 1, 2011. The voting results are as follows:

Proposal 1 – Election of Directors

 

Nominee

   For      Withheld  

James L. Herbert

     17,089,365         843,116   

G. Bruce Papesh

     17,222,583         709,898   

Thomas H. Reed

     16,429,612         1,502,869   

Proposal 2 – To Approve an Increase in the Company’s Authorized Common Shares

The shareholders approved the increase, from 30,000,000 to 60,000,000, in the number of authorized shares of Common Stock.

 

For

    

Against

    

Abstain

    

Broker Non-Vote

 
  17,581,449         3,937,218         43,280         4,419   

Proposal 3 – To Approve an Amendment to the Company’s 2007 Stock Option Plan

The shareholders approved the amendment to the Company’s 2007 Stock Option Plan, increasing the number of shares authorized for issuance to 2,500,000 shares.

 

For

    

Against

    

Abstain

    

Broker Non-Vote

 
  16,343,699         1,440,062         148,719         3,633,886   

Proposal 4 – To Approve the Establishment of the Neogen Corporation 2011 Employee Stock Purchase Plan

The shareholders approved the establishment of the Company’s 2011 Employee Stock Purchase Plan, as described in the proxy materials.

 

For

    

Against

    

Abstain

    

Broker Non-Vote

 
  17,278,068         499,281         155,132         3,633,885   

Proposal 5 – To Approve, by Non-Binding Vote, the Compensation of Executives

The shareholders approved, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the proxy materials.

 

For

    

Against

    

Abstain

    

Broker Non-Vote

 
  16,999,981         554,984         377,515         3,633,886   


Proposal 6 – To Approve, by Non-Binding Vote, the Frequency of Future Shareholder Advisory votes on Executive Compensation

The shareholders approved, on an advisory basis, the Board’s recommendation to hold the shareholder advisory vote on executive compensation annually.

 

Annual

   

Every 2 Years

   

Every 3 Years

   

Abstain

   

Broker Non-Vote

 
  15,174,059        670,421        1,794,022        293,978        3,633,886   

Proposal 7 – Ratification of the Appointment of the Company’s Independent Registered Public Accounting Firm

The shareholders ratified the appointment of Ernst & Young LLP as the Company’s auditors for the fiscal year ended May 31, 2012.

 

For

    

Against

    

Abstain

    

Broker Non-Vote

 
  21,133,159         298,472         134,735         0   


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    NEOGEN CORPORATION
    (Registrant)
Date: October 11, 2011    
   

/s/ Steven J. Quinlan

    Steven J. Quinlan
    Vice President & CFO